arrow
P

Peter Vestergaard Rasmussen

Aarhus University Hospital
H指数:27
被引数:3,798

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Insights from a Danish nationwide implementation of patient-reported outcomes in multiple sclerosis

丹麦全国性实施患者报告结局在多发性硬化中的经验与启示

2026-07-230
PRE
Pediatric Onset Multiple Sclerosis (POMS): Exploring phenotypic characterization and pubertal influences in modulating the disease activity from the Danish MS Registry (DMSR)

儿童期发病多发性硬化(POMS):探索表型特征和青春期影响对疾病活动的调节作用——基于丹麦多发性硬化登记系统(DMSR)

2025-04-280
PRE
Risk of hypertension in patients with multiple sclerosis treated with teriflunomide compared to dimethyl fumarate: A nationwide cohort study in Denmark

与富马酸二甲酯相比,特利氟米特治疗多发性硬化患者的高血压风险: 丹麦的一项全国性队列研究

2024-12-040
PRE
Patterns and predictors of multiple sclerosis phenotype transition

多发性硬化表型转变的模式和预测因素

2024-11-230
OAAI
Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish study

新诊断的特利氟米特治疗的多发性硬化患者疾病活动的预后因素: 一项全国性的丹麦研究

2024-04-030
PRE
Pharmacokinetics and pharmacodynamics of cannabis-based medicine in a patient population included in a randomized, placebo-controlled, clinical trial
2023-12-065
OAAI
Cannabis-Based Medicine for Neuropathic Pain and Spasticity-A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial
2023-07-2811
OAAI
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis
2022-05-305
OAAI
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
2021-09-189
PRE
International consensus on quality standards for brain health-focused care in multiple sclerosis
2018-11-0157
OAAI
Remote Ischemic Perconditioning as an Adjunct Therapy to Thrombolysis in Patients With Acute Ischemic Stroke A Randomized Trial

远程缺血预处理作为急性缺血性卒中患者溶栓治疗的辅助治疗: 一项随机试验

STROKE
IF8.9
2014-01-01247
OA